Olema Pharmaceuticals, Inc. OLMA Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s short-term investments?
- Olema Pharmaceuticals, Inc. (OLMA) reported short-term investments of $452.8M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s short-term investments changed year-over-year?
- Olema Pharmaceuticals, Inc.'s short-term investments increased by 32.4% year-over-year, from $342.07M to $452.8M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s short-term investments?
- Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s short-term investments has grown at a 13.7% compound annual growth rate (CAGR), from $273.44M to $457.14M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.